Elanco to Participate in Morgan Stanley Healthcare Conference

Elanco Animal Health Incorporated (NYSE: ELAN) announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference, taking place on September 15, 2026.

The company will be represented by President and CEO Jeff Simmons and Executive Vice President and CFO Bob VanHimbergen. They are expected to provide updates on the company's strategy and financial performance within the broader healthcare landscape.

The conference brings together leading healthcare companies, investors, and analysts to discuss industry trends and the future outlook. Elanco's attendance offers an opportunity to present its latest advancements and strategic priorities to key industry stakeholders.

Elanco focuses on animal health, offering a range of products and services for the prevention and treatment of animal diseases, including pharmaceuticals, vaccines, and parasiticides.